PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.77%
Both yoy net incomes decline, with AVGO at -63.85%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
7.42%
Less D&A growth vs. AVGO's 151.61%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
49.29%
Some yoy growth while AVGO is negative at -146.01%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
55.88%
Less SBC growth vs. AVGO's 147.96%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-227.14%
Negative yoy working capital usage while AVGO is 70.70%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-38.62%
AR is negative yoy while AVGO is 860.17%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
7.69%
Inventory shrinking or stable vs. AVGO's 75.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-670.00%
Both negative yoy AP, with AVGO at -134.42%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-261.98%
Both reduce yoy usage, with AVGO at -118.23%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-1650.00%
Negative yoy while AVGO is 213.11%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-47.14%
Both yoy CFO lines are negative, with AVGO at -0.27%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-8.71%
Both yoy lines negative, with AVGO at -16.19%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
6500.00%
Some acquisitions while AVGO is negative at -70500.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-89.63%
Negative yoy purchasing while AVGO stands at 77.59%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-22.87%
Both yoy lines are negative, with AVGO at -42.21%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-566.67%
We reduce yoy other investing while AVGO is 81.01%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-970.42%
Both yoy lines negative, with AVGO at -20445.97%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-57.09%
Both yoy lines negative, with AVGO at -20232.87%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
44.44%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
95.38%
We have some buyback growth while AVGO is negative at -1336.74%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.